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REVIEW ARTICLE OPEN
Mechanisms of activation of innate-like intraepithelial
T lymphocytes
Maud Vandereyken1, Olivia J. James1 and Mahima Swamy1
Intraepithelial T lymphocytes (T-IEL) contain subsets of innate-like T cells that evoke innate and adaptive immune responses to
provide rapid protection at epithelial barrier sites. In the intestine, T-IEL express variable T cell antigen receptors (TCR), with
unknown antigen specificities. Intriguingly, they also express multiple inhibitory receptors, many of which are normally found on
exhausted or antigen-experienced T cells. This pattern suggests that T-IEL are antigen-experienced, yet it is not clear where, and in
what context, T-IEL encounter TCR ligands. We review recent evidence indicating TCR antigens for intestinal innate-like T-IEL are
found on thymic or intestinal epithelium, driving agonist selection of T-IEL. We explore the contributions of the TCR and various co-
stimulatory and co-inhibitory receptors in activating T-IEL effector functions. The balance between inhibitory and activating signals
may be key to keeping these highly cytotoxic, rapidly activated cells in check, and key to harnessing their immune surveillance
potential.
Mucosal Immunology _#####################_ ; https://doi.org/10.1038/s41385-020-0294-6
INTRODUCTION
Intestinal intraepithelial T lymphocytes (T-IEL) constitute the
largest T cell compartment in the body, with a ratio of at least 1
T-IEL for every 10 epithelial cells lining the entire human
gastrointestinal tract.1 T-IEL are commonly classified into two
main groups based on their mode of selection in the thymus, and
their functional potential: induced, adaptive or conventional T-IEL
and natural, innate-like or unconventional T-IEL.2,3 Induced T-IEL
develop from conventional CD4+ or CD8αβ+ TCRαβ+ T cells that
are activated post-thymically in response to peripheral antigens,
and then migrate to the gut as memory-type lymphocytes. In the
murine small intestine, the majority of the induced T-IEL are TCRαβ
CD8αβ+, whereas CD4+ cells account for only 10% of the total T-
IEL population. Natural T-IEL are thought to acquire their
phenotype in the thymus upon self-antigen encounter, although
this is still debated, and are CD4− and CD8αβ−, therefore
sometimes referred to as double-negative (DN) T-IEL.4,5 These
natural T-IEL are also referred to as innate-like due to their ability
to be activated by cytokines and other innate ligand-receptor
axes, in a TCR-independent manner. The majority of murine
innate-like T-IEL are characterized by the expression of CD8αα
homodimers, and express either TCRαβ or TCRγδ. These innate-
like T-IEL comprise up to 80% of murine T-IEL and share a gene
expression profile that is distinct from induced IEL.3 Based on this
gene expression profile, innate-like T-IEL also exist in humans and
represent 5–30% of the T-IEL compartment, although they rarely
express CD8αα (Table 1). The human adult IEL compartment is
therefore mainly composed of induced TCRαβ CD8αβ (∼80%) and
TCRαβ CD4 (∼10%) T-IEL.6 It should be noted here that these so-
called induced T-IEL are antigen-experienced T cells that also have
the capacity to respond in an antigen-independent manner, and
exhibit other innate-like characteristics, such as expression of NK
receptors7–9 (Table 1). Thus the distinction between these two cell
types within the epithelium may be blurred, in order to permit IEL
to rapidly respond to changes at the epithelium.
T-IEL are thought to play a critical role in preserving the
intestinal barrier integrity by controlling the growth, turnover and
repair of the epithelium, while also defending it from infection.10
Studies using TCRδ-deficient mice lacking γδ T cells highlighted a
critical role of γδ T-IEL in influencing turnover and differentiation
of intestinal epithelial cells (IEC)11 and in maintaining mucosal
homeostasis. This function of T-IEL has been particularly shown to
be important in the recovery from colitis-inducing chemicals in
mouse models.12,13 Conversely, T-IEL are also cytotoxic cells that
patrol the epithelial layer to sense and eliminate infected/
damaged epithelial cells.14 They are activated in response to oral
infections with pathogens such as Salmonella,15,16 Rotavirus,17 and
Toxoplasma gondii,18 and at least in the context of loss of γδ T-IEL
function, they appear to restrict pathogen entry.15,16,19,20 Given
their constant exposure to the gut microenvironment they must
have the capacity to tolerate commensal bacteria while also being
able to quickly recognize and fight enteric pathogens. To achieve
this, they are kept in an “activated, yet resting” state, ready for
action, but tight control of this poised activation state is essential.2
If this control is disrupted, T-IEL might potentially exacerbate the
intestinal damage found in autoimmune and inflammatory bowel
diseases (IBD)21–25 such as Crohn’s and coeliac disease. It is
therefore of vital importance to understand which signals activate
T-IEL cytotoxic responses, and which signals trigger their tissue
reparative functions.
Here, we discuss recent evidence indicating that T cell antigen
receptors (TCR) ligands for some innate-like T-IEL can be found on
epithelial cells and are essential for their selection and maturation.
We also review the data addressing whether the TCR is an
activating receptor on innate-like T-IEL. In addition to their TCR,
both induced and innate-like T-IEL express many unconventional
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Table 1. Intestinal human and murine innate-like subset representation, their TCR repertoire and receptor expression profile.
T-IEL type TCR ligands Receptors expressed
Mouse
Innate-like TCRγδ CD8αα Nonclassical MHC; Btnl1/Btnl6 (Vγ7) NKG2Da; CD160b; CD100b; Ly49Eb; CD200Rb; 2B4b; JAMLb; LAG-3b;
TIGITb; Gp49b
Innate-like TCRαβ CD8αα Classical and nonclassical MHC class I and II
(cross-reactive)
NKG2Da; CD160b; CD100b; Ly49 familyb; CD200Rb; CD94/NKG2a,b;
2B4b; JAMLb; LAG-3b; TIGITb; Gp49b
Induced TCRαβ CD8αβ or CD4 MHC class I or II CD160b; CD100b; CD200Rb; 2B4b; JAMLb; CTLA-4b
Human
Innate-like TCRγδ Nonclassical MHC; BTNL 3/8 (Vγ4) NKp46b
Innate-like TCRαβ unknown unknown
Induced TCRαβ CD8αβ or CD4 MHC class I or II NKG2Da; CD94/NKG2a,b; Nkp46a
T-IEL subset composition differ from humans to mice. In humans, induced TCRαβ CD8αβ T-IEL are predominant while in mice, the majority of T-IEL is
composed of innate-like T-IEL (TCRαβ CD8αα and TCRγδ CD8αα). In addition to their TCR, human and murine T-IEL express numerous activating and inhibitory
receptors, suggesting alternative modes of activation.
aExpression induced by inflammatory signals or in the context of disease.
bConstitutively expressed.
Fig. 1 Stimulatory receptors expressed on intestinal intraepithelial T lymphocytes. T-IEL express (co)stimulatory receptors (NKG2D, CD94,
CD100, JAML, and CD160) that regulate TCR activation, T-IEL cytotoxicity and their cytokine production. Associated ligands are often found
within the intestine, mainly at the surface of epithelial cells. The expression of some receptors and their ligands can be modulated by the
microenvironment. For example, NKG2D is upregulated when cells are exposed to high levels of IL-15 and expression of NKG2D ligands
and BTNL molecules are modulated by cell stress and inflammation. Although it is still not clear how these (co)stimulatory receptors regulate
innate-like T-IEL activation, known signaling events are depicted. T-IEL cytotoxicity triggered by NKG2D activation in coeliac disease depends
on PI3K/ERK and JNK-mediated cPLA2 activation. Conversely, CD100 engagement on γδ T-IEL is important for wound repair, possibly through
the production of KGF-1. In addition to inducing cytokine production and enhancing T-IEL cytotoxicity, receptor-ligand engagement can also
trigger signaling in epithelial cells, as evidenced by HVEM engagement on epithelial cells leading to enhanced bacterial clearance in infection.
(h) human; (m) mouse; Ig immunoglobulin, CRD cysteine-rich domain, GPI glycosylphosphatidylinositol, PSI domain plexins, semaphoring and
integrin domain, IPT domain Ig-like, plexin and transcription factors domain, ITAM immunoreceptor tyrosine-based activation motif, TNF
tumor necrosis factor, PI3K Phosphoinositide 3 kinase, pPI3K phosphorylated PI3K, pJNK phosphorylated c-Jun N-terminal Kinase, pERK1/2
phosphorylated Extracellular signal-Regulated Kinase 1/2, cPLA2 cytosolic Phospholipase A2, KGF keratinocyte Growth Factor, pSTAT3
phosphorylated Signal Transducer and Activator of Transcription 3.
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signaling receptors not normally found on naïve T cells, such as
NKG2D, 2B4 and CD160, which suggest alternate modes of
activation, that may or may not involve the TCR (Fig. 1).
Conversely, T-IEL express a slew of co-inhibitory receptors that
may be key to keeping these highly cytotoxic, rapidly activated
cells in check (Table 1 and Fig. 2). The importance of these
receptors on T-IEL are the subject of many new studies, and herein
we review them to provide an overview of our understanding of T-
IEL activation and regulation. We also draw on comparisons with
studies of skin-resident dendritic epidermal T cells (DETCs), as an
example of a tissue-resident γδ T-IEL population whose activation
has been evaluated in more detail, due to the better tools
available to study this innate-like T cell population.
THE T CELL ANTIGEN RECEPTOR
Expression of a TCR is the defining feature of T cells, and its
engagement by antigen is considered essential for T cell function.
In this section we explore the relevance of the TCR for the
selection of innate-like T-IEL and for their functional activation.
SELECTION OF ANTIGEN SPECIFICITIES OF INTESTINAL T-IEL
TCRS
Both αβ and γδ T-IEL derive their TCRs from recombination-
activating genes (RAG)-dependent gene rearrangements that
occur in developing precursors in the thymus. Initial studies
showed that, while there was some bias in V gene usage, intestinal
innate-like αβ T-IEL are essentially oligoclonal populations with
diverse TCRs that undergo clonal expansion in the gut.26,27
Conversely, the majority of intestinal γδ T-IEL express the Vγ7
gene, although this chain still has considerable junctional
diversity, and is paired with diverse Vδ chains.28–30 This is in
contrast to DETC in the murine skin, where >90% of the cells
express the Vγ5Vδ1 TCR. The DETC TCR is selected in the fetal
thymus by an immunoglobulin superfamily molecule, the Selec-
tion and upkeep of intraepithelial T-cells protein 1 (Skint1).31
Although formal proof that Skint1 can bind to the Vγ5Vδ1 TCR is
still lacking, modeling studies and in vitro analyses suggest this to
be the case,32 and it is thought that intrathymic Skint1-TCR
interaction drives DETC selection and maturation.
The search for a Skint1-equivalent molecule for the selection
and function of intestinal γδ T-IEL lead to the discovery of
Butyrophilin-like (Btnl) family of molecules.33 Btnl1 is expressed as
a heterodimer with Btnl6 on IEC under homeostatic conditions.34
Hayday and colleagues recently demonstrated that in the absence
of Btnl1, Vγ7+ T-IEL were almost absent from the intestinal
compartment35 (Fig. 1 and Table 1). Critically, they could
demonstrate that the Vγ7 TCR is essential for the response to
Btnl1/Btnl6, and thus drives the selective expansion and matura-
tion of Vγ7+ T-IEL.36 They also identified the human equivalent
molecules, BTNL3/BTNL8 dimers on enterocytes, to be a similar
selection molecule for Vγ4-expressing T-IEL in the human gut,35–37
thus providing the first evidence of intestinal epithelial expression
of a TCR-selecting ligand, and of extrathymic selection and
maturation of T-IEL. Intriguingly, continuous expression of BTNL3/
8 seems to be required to maintain Vγ4+ T-IEL populations, as loss
of BTNL3/8 expression in coeliac disease patients correlated with a
loss of Vγ4+ T-IEL from the human gut.38
With regards to innate-like αβ T-IEL, much progress has been
made in exploring the selection pressures that drive specific TCR
usage. Mayans et al.39 cloned the TCRs from DN (i.e. CD8αα) T-IEL
and expressed these retrogenically in bone marrow (BM) to
address whether the TCR is important for T-IEL selection.
McDonald et al.40 also cloned αβ TCRs from adaptive and
innate-like intestinal T-IEL populations and expressed them
conditionally at the CD4+CD8+ double positive stage of thymic
development in a mixed BM chimera system. Consistently,
unconventional TCRs lead to the development of natural T-IEL,
and conventional TCRs lead to the development of splenic CD8+
Fig. 2 Inhibitory receptors expressed on intestinal intraepithelial T lymphocytes modulate their function. In addition to (co)stimulatory
receptors, innate-like T-IEL express inhibitory receptors such as CD8αα, CD200R, 2B4, Ly49, and CD94/NKG2A that regulate TCR activation,
their proliferation, their cytotoxicity, and their cytokine production. CD8αα and Ly49 are only expressed by murine T-IEL. 2B4 expression is
induced by gut microbiota and CD70 co-stimulation. TCR engagement and IL-15 upregulate CD94 expression. Like (co)stimulatory receptor
ligands, ligands for inhibitory receptors are often found within the intestine, mainly at the surface of epithelial cells, suggesting that inhibitory
receptor engagement is necessary for keeping T-IEL in an “activated, yet resting” state. Indeed, by preventing aberrant T-IEL proliferation,
cytotoxicity and cytokine production, inhibitory signals may maintain T-IEL and gut homeostasis. In line with this, in coeliac disease, the CD94/
NKG2A heterodimer expression is selectively downregulated while CD94/NKG2C pair is upregulated, tipping the balance toward effector
function of T-IEL. (h) human; (m) mouse; Ig immunoglobulin, GPI glycosylphosphatidylinositol, ITAM immunoreceptor tyrosine-based
activation motif, ITIM immunoreceptor tyrosine-based inhibitory motif, TL thymus Leukemia antigen.
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T cells or induced CD8+ αβ T-IEL. Together, both papers showed
that strong agonist selection through the TCR drives the
development of DN T-IEL from the thymus with further maturation
taking place in the gut environment. Further, the cloned TCRs
were not restricted on conventional major histocompatibility
complex-1 (MHC-I), but were still mostly β2 microglobulin (β2m)-
dependent, indicating their recognition of non-classical MHC-I,
although some seemed to be cross-reactive, including one TCR
that was MHC-II restricted. Indeed, the pool of negatively selected
thymocytes from which T-IEL precursors develop express TCRs
that are inherently cross-reactive to both MHC-I and MHC-II,41
which may be an important factor in the downregulation of both
CD4 and CD8αβ. This was corroborated by another detailed study
of CD8αα T-IEL precursors.42 This study also identified a distinct
precursor population of CD8αα T-IEL, that more closely resembled
iNKT cells, and was restricted on non-classical MHC-I and CD1d.
ROLE OF THE TCR IN T-IEL ACTIVATION
The TCR is essential to activate functional responses in conven-
tional T cells, and even for survival of some T cell subsets.43–45 In
contrast, we do not know if T-IEL need functional TCRs and the
TCR signal transduction machinery in order to get activated.
Innate-like T cells are so called because of their ability to respond
to cytokines and activating NK receptor ligands in the absence of
TCR ligands. So, for example, CD27-ve γδ T cells respond to the
cytokines IL-1β and IL-23 to produce IL-17A,46 DETC respond to
activation through the natural killer group 2D (NKG2D) receptor,47
and MAIT cells respond to IL-12 and IL-18 to produce Interferon γ
(IFNγ).48
Notably, some innate-like T cell populations appear to have
developmentally switched off TCR signaling. Thus, although
thymic DETC progenitors are able to mobilize calcium in response
to agonistic antibodies to the TCR, DETC isolated from the skin are
no longer able to respond to TCR stimulation.49 Likewise, the TCR
on both αβ and γδ innate-like intestinal T-IEL has been shown to
be refractory to anti-CD3 mediated TCR triggering.49,50 Surpris-
ingly, in vivo, the DETC TCR is constitutively phosphorylated and
its downstream kinase Zap70 is enriched in epithelial contact
zones of DETC.51 The putative DETC TCR ligand, Skint1, is
constitutively expressed in the skin, providing a mechanism for
constant TCR triggering in vivo that may be required for
maintaining DETC. However, DETCs did not require a key TCR
signaling intermediate, the Linker for Activation of T cell (LAT), for
their long-term survival and homeostasis.52 Conversely, LAT was
required for the DETC response to wounding of the skin,52 and
DETC TCR tetramers bound to damaged keratinocytes even in
mice lacking Skint1,53 implying the presence of a stress-induced
TCR ligand that drives TCR activation for the immunosurveillance
function of DETC.
In the context of γδ T-IEL, it is significant that Btnl1 is also
constitutively expressed in the gut and that Vγ7+ T-IEL from
Btnl1−/− mice are more responsive to TCR agonistic antibodies
than the corresponding cells from Btnl1+/+ mice.35 These data
imply that constant Vγ7 TCR engagement by Btnl1 may be
responsible for downmodulating TCR responsiveness. Primary
Vγ7+ T-IEL co-cultured with MODE-K cells expressing Btnl1/Btnl6
dimers upregulated CD25, CD71, and Nur77-GFP, indicators of
active TCR signaling.36 These responses were blocked by PP2, a
pan-Src kinase inhibitor, supporting the notion that TCR engage-
ment of Btnl molecules triggers TCR signaling. The human BTNL3/
8-responding T-IEL express Vγ4, and through sequence analyses
and comparisons with murine Vγ7, a critical interaction site with
BTNL3/8 could be identified in framework region 3 (also known as
hypervariable region 4) in the variable region of the gamma chain
for both human Vγ4 and mouse Vγ7. Indeed, the binding of BTNL3
to human Vγ4 TCR was recently confirmed using surface plasmon
resonance and other binding studies.37 This allowed the authors
to make molecular modeling-based predictions about the binding
geometry of Btnls to the TCRs. The data indicated that Btnls most
likely bind in a non-conventional side-on conformation, akin to
superantigens, molecules that can activate T cells independent of
their TCR specificity. This also implies that Btnl binding to the T-IEL
TCR still leaves the variable regions of the TCR free to bind to
another ligand in the gut, that could be induced similar to the
putative DETC TCR ligand mentioned above. However, the recent
study by Willcox et al.37 indicates that it is unlikely that the TCR
engages another ligand and a Btnl molecule simultaneously.
With the identification of TCR ligands for γδ T-IEL, and the
indication of broad MHC reactivity of the TCRs on TCRαβ CD8αα T-
IEL, we can begin to make predictions about the functions of the
TCR on T-IEL. The data above indicate that innate-like T-IEL need
the TCR for selection, and potentially expansion and retention
in the gut. However, BTNL ligands appear to be downregulated in
the context of both chronic inflammatory diseases and colorectal
cancer38,54 suggesting that they do not activate IEL function in the
gut. Additionally, both classical and non-classical MHC molecules
can be constitutively and inducibly expressed by epithelial cells,
however, it is unknown whether the endogenous, strong agonistic
TCR ligands that select innate-like αβ T-IEL are expressed by IEC.
Thus, it would appear contradictory to assume that stimulation of
the TCR is needed for activation. Indeed, blocking TCR signaling
using inhibitors against the TCR proximal kinases Zap70/Syk, or
blocking antibodies, did not prevent infection-induced changes in
γδ T-IEL migration and defense.20 Given that agonistic TCR
antibodies do not induce signaling in both αβ and γδ innate-like
T-IEL,49,50 other mechanisms must be in place to activate T-IEL.
Below we present other receptors that may drive T-IEL activation,
either directly, or, in a manner analogous to exhausted or antigen-
experienced cells, by removing the inhibitory signals on T-IEL.
OTHER (CO) STIMULATORY RECEPTORS
A characteristic shared by innate-like T cells is that they express, in
addition to the TCR, a wide range of activating and inhibitory NK
receptors, indicating possible TCR-independent activation
mechanisms. In the intestine, expression of such receptors is not
limited to innate-like T-IEL as both human and murine induced
T-IEL express NKG2D and CD94. In the following sections, in
addition to reviewing data on the role of those receptors in
innate-like T-IEL, we will also comment on evidence showing that
induced T-IEL may undergo innate-like activation through NK
receptors, specifically in the context of disease (Fig. 1 and Table 2).
NATURAL KILLER GROUP 2D
NKG2D was one of the first receptors identified as an activator of
human αβ T-IEL cytotoxicity.55 NKG2D is a type II transmembrane
C-type lectin activating receptor. It recognizes ligands upregulated
by transformation, infection or cell stress, such as MICA/MICB and
ULBP family members in humans, and Rae1, H60, and MULT1 in
mice (Fig. 1). In humans, NKG2D is found at the surface of both
resting and activated CD8+ T cells while murine T cells only
express NKG2D when activated.56 Consistent with this, NKG2D is
found at the surface of all murine DETC57 and human intestinal
T-IEL, albeit at low levels.55 Although NKG2D is not expressed at
the surface of murine intestinal T-IEL in normal conditions,
cytokine-dependent NKG2D upregulation has been observed
during infections. Hence, IL-15 mediates NKG2D expression on
CD8αα T-IEL following poly(I:C) treatment in vivo,58 infection with
Entamoeba moshkovskii triggers IFNγ production which is required
for NKG2D expression on TCRαβ CD8αα T-IEL,59 and increased IL-
1β production regulates γδ T-IEL NKG2D expression following
Salmonella typhimurium infection in TLR9−/− mice.60 Of note, in
addition to upregulating NKG2D expression, these cytokines also
facilitated NKG2D ligand expression on epithelial cells.59,60
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NKG2D engagement triggers cytotoxicity of NK cells and T-IEL.
Human intestinal CD8αβ T-IEL spontaneously kill selected colon
cancer cell lines that express even low levels of NKG2D ligands, by
triggering FasL-mediated cytotoxicity.61 However, freshly isolated
human T-IEL did not kill other cell lines when triggered with anti-
NKG2D antibodies,55 suggesting that colon cancer cell lines
express other factors that enhance their killing. Murine poly(I:C)-
treated intestinal T-IEL kill primary poly(I:C)-treated IEC in vitro and
in vivo dependent on NKG2D/Rae-1 interactions.58 Infection of
mice with Salmonella16 and E. moshkovskii59 also triggers NKG2D-
mediated cytotoxicity of T-IEL against epithelial cells. NKG2D also
functions as a potent costimulator of TCR-induced IFNγ produc-
tion and proliferation of human intestinal T-IEL.55
Although human intestinal induced T-IEL constitutively express
NKG2D, its expression can be further upregulated by IL-15.55 In
coeliac disease, NKG2D-mediated IEL cytotoxicity is thought to be
Table 2. Complete list of receptors known to be expressed by intestinal intraepithelial T lymphocytes, their ligands and their context-dependent
functions.
Receptor Alternative names Ligands Ligand
expression on IEC
Function Context
NKG2D Klrk1 (gene) MICA/MICB, ULBP (human)
Rae-1, H60, MULT1
(mouse)
Induced56 Induced56 Costimulatory/
stimulatory
In vitro killing assay55,57,61
Poly(I:C) treatment58
Salmonella and E. moshkovskii
infection59,60
Coeliac disease62–64
CD160 By55 HVEM (high affinity)
Classical and non-classical
MHC-I molecules (low
affinity)
Yes74
Yes
Costimulatory
N/A
Listeria monocytogenes
infection75
C.rodentium infection74
CD100 Sema4D Plexins B1 and B2
CD72
Yes76
No76
Costimulatory DSS-induced colitis (γδ T-
IEL)77
CD8αα Thymus leukemia
antigen (TL)
Yes84 Inhibitory In vitro costimulation85,91
Spontaneous model of T-cell-
dependent colitis89
Ly49 Family MHC-I molecules Yes Inhibitory
No effect
In vitro costimulation95
DSS-TNBS-induced colitis
and TNFΔARE ileitis model99
AOM-DSS-induced colorectal
cancer98
CD200R OX2R CD200
iSEC1, iSEC2
No102
Yes102
Inhibitory In vitro anti-CD3
stimulation102
CD94 HLA-E (human)
Qa-1b (mouse)
Yes124
Yes16
Inhibitory (NKG2A
dimerization)
Costimulatory (NKG2C or
E/H dimerization)
In vitro anti-CD3
stimulation95,105
in vitro anti-CD3
stimulation105
Coeliac disease108,109
2B4 SLAMF4
CD244.2
CD48 (SLAMF2) N/A Inhibitory Ex vivo and in vivo anti-CD3
stimulation95
JAML AMICA1 CAR Yes117,118 Costimulatory In vitro costimulation (γδ T-
IEL only)117
OX40 CD134
TNFRSF4
OX40L (gp34, CD252,
TNFSF4)
No Costimulatory In vitro anti-CD3 and anti-
OX-40 stimulation119
NKp46 CD335
NCR1
Various viral and bacterial
proteins
Stimulatory In vitro cytotoxic assay108,120
NKp44 CD336
NCR2
Various viral and bacterial
proteins
N/A N/A
LAG-3 CD223 MHC-II molecules
FGL1
Induced125,126
N/A
N/A N/A
NKR-P1a CD161
KLRB1
LLT1/CLEC2D (h) Yes127 N/A N/A
4-1BB CD137
TNFRSF9
4-1BBL (CD137L, TNFSF9) N/A N/A N/A
Gp49 LILRB4
ILT3
CD85k
Unknown N/A N/A N/A
TIGIT VSig9, Vstm3, WUCAM CD155
CD112
Yes128
N/A
N/A N/A
PD-1 CD279 PD-L1 Induced129 N/A N/A
CTLA-4 CD152 B7.1/2 Yes130 N/A N/A
N/A no data available, IEC intestinal epithelial cells, T-IEL intraepithelial T lymphocytes, DSS dextran sodium sulfate, TNBS trinitrobenzenesulfonic-acid, AOM
azoxymethane.
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responsible for epithelial destruction.62,63 In the disease context,
the chronic heightened expression of IL-15 by stressed IEC plays a
critical role as IL-15 not only upregulates NKG2D expression on T-
IEL, but also primes the cells and potentiates their cytotoxicity.63
NKG2D-mediated cytotoxicity depends on the phosphorylation of
c-Jun N-terminal Kinase (JNK) and the activation of Extracellular
signal-Regulated Kinase (ERK) by Phosphoinositide 3 kinase
(PI3K)62–64 and the subsequent activation of cytosolic Phospho-
lipase A2 (cPLA2)
64 (Fig. 1). Interestingly, in vitro stimulation of
human intestinal T-IEL by IL-15 enhanced ERK phosphorylation by
PI3K as well as JNK and cPLA2 activation, and without this pre-
stimulation, triggering of NKG2D on T-IEL could not induce
degranulation.64 All these studies highlight a significant stimula-
tory function of NKG2D on T-IEL; however, it would appear that in
most cases, it is not possible to rule out the simultaneous
engagement of other receptors on T-IEL, nor licensing by IL-15 or
other factors to permit NKG2D-mediated cytotoxicity.
CD160
CD160 (recognized by the monoclonal antibody BY55) is an IgV-
like domain membrane protein that was first identified on
intestinal IEL65 (Fig. 1). Following alternative splicing, CD160 is
found at the surface of cells either as a transmembrane receptor or
attached by a glycophosphatidylinositol (GPI)-anchor.66 CD160 is
expressed by both human and murine NK, T cells, NKT, Innate
lymphoid cells 1 (ILC1), and CD8+ T-IEL,65,67–69 but the transmem-
brane isoform is restricted to NK cells.66 CD160 binds, with a low
affinity, to classical and non-classical (CD1d) MHC-I molecules70–72
and with high affinity to the herpesvirus entry mediator (HVEM).73
Expression of CD160 by immune cells is possibly tissue- and
microenvironment-dependent since in the colon of mice, it is
restricted to T-IEL, most particularly to the CD8αα subset.74 Since
HVEM is expressed by IEC, this suggests a role for CD160/HVEM in
epithelial-mediated T-IEL response against pathogens. In line with
this, HVEM−/− mice displayed reduced epithelial integrity and
bacterial clearance upon Citrobacter rodentium infection, as
compared to wild-type (WT) mice. Binding of CD160 to HVEM
on epithelial cells triggers Signal Transducer and Activator of
Transcription 3 (STAT3) activation and subsequent expression of
genes involved in response against pathogens.74 As IEL appear to
be the major expressers of CD160 in the gut, it was postulated that
CD160 on IEL binds to HVEM on IEC to drive these effects.
Opposing results came from a recent study showing that loss of
CD160 on T-IEL did not affect C. rodentium host defense.75
However, CD160 was important for Listeria monocytogenes
clearance, as 7 days post infection, CD160−/− mice had more
bacteria in the colon than WT mice. The authors associated the
higher burden of bacteria with impaired Granzyme B expression
and cytokine production by CD8+ T cells in CD160-deficient mice.
These results suggest that engagement of CD160 positively
regulates T-IEL, highlighting a stimulatory role of CD160 on T-IEL.
CD100
CD100, also known as Sema4D, is a type IV transmembrane
semaphorin that is highly expressed on T cells, with enhanced
expression following activation, and to a lesser extent on NK, B
cells, and antigen presenting cells (APCs).76 It is also found at the
surface of all colonic T-IEL.77 CD100 binds to Plexins B1 and B2,
which have broad expression and CD72, present on the surface of
B cells and dendritic cells (DCs)76 (Fig. 1).
CD100 is known to have a costimulatory role in T cells78 and in
CD100-deficient mice peripheral T cells function is impaired.79,80
More recently, CD100 was shown to bind to plexin B2 on
keratinocytes and IEC to enhance γδ T cell responses.81 In this
context, CD100 deficiency, specifically on DETCs and not any
other T cells, led to delayed epidermal wound repair due to an
inability of DETC to make morphological changes necessary for
an effective response to tissue damage. These CD100-mediated
morphological changes in DETC were shown to be ERK-
dependent.81 In acute Dextran sodium sulfate (DSS)-induced
colitis, CD100-deficiency led to enhanced susceptibility to the
disease and a failure to resolve intestinal damage. The effect was
attributed to CD100−/− γδ T-IEL being unable to produce
Keratinocyte Growth Factor (KGF), an important growth factor in
stimulating epithelial proliferation. However, KGF production
could not be stimulated by CD100 cross-linking on γδ T-IEL
in vitro, suggesting that CD100 regulates γδ T-IEL functions in
concert with other signals. Interestingly, although only γδ T-IEL
secrete KGF, both CD100−/− colonic γδ and αβ T-IEL were shown
to have defective proliferative capacity following DSS-induced
colitis.77 However, plexin B2-CD100 interactions did not play a
role in αβ T cell activation in vitro,81 suggesting that while
CD100 is highly expressed on all T cells, it functions in a subset-
and site-specific manner, perhaps depending on the type of
ligand expressed.
INHIBITORY RECEPTORS
In addition to the expression of many (co)stimulatory receptors,
murine T-IEL express various inhibitory receptors that are thought
to curb spurious T-IEL activation (Fig. 2 and Table 2). They are the
focus of this section.
CD8αα
A defining characteristic of murine innate-like intestinal T-IEL is
their exclusive expression of the CD8αα homodimer. CD8αα
expression on lymphocytes is regulated by the intestinal environ-
ment as conventional CD4+ T cells also upregulate CD8αα
expression upon migration to the intestine.82,83 CD8αα binds with
high affinity to the Thymus Leukemia Antigen (TL),84–88 a
nonclassical MHC-I molecule, whose expression is restricted to
murine IEC. Unlike the TCR co-receptor CD8αβ expressed on
conventional lymphocytes, CD8αα engagement negatively reg-
ulates TCR activation.89 CD8αα/TL interaction is thought to restrain
T-IEL homeostatic proliferation90 and survival,85 preventing aber-
rant T-IEL proliferation without interfering with their immune
functions. It has also been reported that TL/CD8αα interaction
modulates T-IEL production of cytokines such as IL-2 and IFNγ and
curbs T-IEL cytotoxicity.85,91 Yet TL deficiency does not lead to
spontaneous colitis/IBD nor does it affect the outcome of
chemically-induced colitis in mice. Interestingly, in TCRα−/− mice,
which spontaneously develop IBD, colitis developed earlier and
was more severe when TL was concurrently deleted. This was
linked to an increased secretion of IL-4 by TL−/− TCRββ T-IEL, not
usually found in normal context.91 Nevertheless, the involvement
of CD8αα in the disease development is still unclear as TCRββ T-IEL
do not express CD8αα. It is possible that TCRγδ T-IEL, which express
CD8αα, are involved in the disease development. Alternatively, TL
binding may not be restricted to CD8αα (and vice versa), and thus
TL and CD8αα may function independently of each other.
LY49 FAMILY AND LY49E
The Ly49 receptors are murine functional homologs of human
killer cell immunoglobulin-like receptors (KIR), and function as
receptors for MHC-I. They are homodimeric type II glycoproteins of
the C-type lectin-like superfamily and can be inhibitory or
activating (Fig. 2). Ly49 receptors are expressed on innate immune
cells (NK, NKT, DC, neutrophils, and macrophages) as well as on
CD8+ T cells and each of these cell type express a unique
complement of Ly49 receptors.92
All IEL express Ly49 receptors but the different populations of T-
IEL do not share the same level of Ly49 receptor expression.
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Instead, 40% of TCRαβ CD8αα T-IEL are positive for members of
Ly49 family when stained with a mixture of antibodies targeting
Ly49A/C E/F/G2 against 10% of TCRγδ CD8αα T-IEL and <2% of
TCRαβ CD8αβ T-IEL. TCRαβ CD8αα T-IEL mostly express Ly49E and
Ly49F, where the Ly49E+ and Ly49F+ populations are nonoverlap-
ping, and TCRγδ CD8αα T-IEL express Ly49E.93–95 Ly49E receptor is
also found on the surface of DETC.96
TCRαβ CD8αα T-IEL expressing Ly49 receptors are hypo-
responsive to TCR triggering, despite the capacity of these
receptors to functionally couple to the TCR in an MHC-I
independent way. Sequestration of these receptors, however,
enhanced TCR stimulation, suggesting Ly49 receptors suppress
TCR-mediated activation of T-IEL.95 In line with Ly49 receptors
regulating T-IEL activation, in vitro TCR-mediated activation of skin
and intestinal TCRγδ T-IEL results in an upregulation of Ly49E
expression due to de novo synthesis of Ly49E molecules.
Induction of Ly49E expression might indicate a negative
regulatory feedback loop as basal and de novo expression of
Ly49e gene seem to be differentially initiated and regulated
depending on the activation state of T-IEL.97
Comprehensive studies led by Leclercq and colleagues ruled
out a functional role for Ly49E receptors in cancer or colitis
immune responses in mice. By comparing tumor size and
frequencies in a mouse model of familial intestinal cancer,
ApcMin/+ Ly49E WT, and ApcMin/− Ly49E KO, as well as in a model
of Azoxymethane (AOM)-DSS-induced colorectal cancer, the
authors showed that tumor development and progression was
not affected by Ly49E deletion.98 The same group also showed
that the severity of inflammation in DSS and TNBS-induced colitis
and the TNFΔARE ileitis models was similar in Ly49E KO and
littermates control mice, indicating that the development and
progression of IBD is not influenced by Ly49E expression on T-IEL
in the systems examined.99
CD200 RECEPTOR 1 (CD200R1)
CD200R1 is one of a paired receptor family that comprises 5 members
(CD200R1, CD200R2–5, or CD200R-like receptors). Unlike the other
members of the family that are activating, CD200R1 is an inhibitory
receptor. It has three tyrosine residues that transduce inhibitory
signals following phosphorylation by recruiting the adapter protein
downstream of tyrosine kinase 2 (Dok2) and activating Ras GTPase-
activating protein (RasGAP).100 CD200R1 is expressed by most
myeloid and lymphoid cells and has been mainly studied in
myeloid-type cells where it seems to play an anti-inflammatory
role.101 CD200R1 is highly expressed on intestinal T-IEL.102
So far, three CD200R1 ligands have been discovered in mice:
CD200 and the intestinal secretory cell-expressed 1 and 2 (iSEC1
and iSEC2).102 CD200 is broadly expressed and the two recently
described CD200R1 ligands, iSEC1 and 2, are only expressed
on IEC of the secretory lineage. Kojima et al., showed that all
T-IEL constitutively express CD200R1 and that both iSEC1 and
CD200 bind to CD200R1 on T-IEL. Co-stimulation of IL-2
stimulated T-IEL with anti-CD3 and iSEC1 or CD200 negatively
affected IFNγ and TNFα production and inhibited T-IEL cytotoxic
activity against a murine colonic adenocarcinoma cell line.102
These results suggest that CD200R1 binding to its ligands
negatively regulates T-IEL functions, similar to its function on
DETC.103 Further studies are awaited to address if
CD200R1 signaling impacts intestinal T-IEL function in vivo,
and whether iSEC1 and iSEC2 are the main ligands driving
CD200R1 activation.
CONTEXT-DEPENDENT REGULATORY RECEPTORS
This section focuses on receptors, such as CD94 and 2B4 that have
been shown to exert both activating and inhibitory functions
(Figs. 1 and 2; Table 2).
CD94
CD94 is a glycoprotein that associates with members of the NKG2
family to form heterodimeric receptors transducing either
inhibitory or activating signals. CD94/NKG2 receptor pairs
are classic NK cell receptors (NKR) found abundantly on NK
cells where they bind to ubiquitously expressed non-classical
MHC class I molecule, HLA-E in humans, and Qa-1b in mice (Figs. 1
and 2). CD94/NKG2A (inhibitory) and CD94/NKG2C, NKG2E/H
(activating) receptor pairs are also prominently expressed by
subsets of memory/effector CTL and T-IEL.104,105 In humans, ~30%
of T-IEL express CD94 and most of these cells are TCRαβ CD8αβ+.
Within these, ~40% express the inhibitory NKG2A receptor pair. In
functional studies using T-IEL cell lines, it was shown that T-IEL
expressing NKG2A, regardless of co-expression of activating NKG2
types, were capable of inhibiting TCR-mediated cytolysis, suggest-
ing that the inhibitory phenotype is dominant105 (Fig. 2).
Conversely, CD94 cross-linking of CD94/NKG2C or NKG2E/H-
expressing T-IEL cell lines markedly enhanced TCR-mediated
cytolysis (Fig. 1). Similar results have also been obtained in mice,
except that in mice TCRαβ CD8αα T-IEL express higher levels of
the inhibitory CD94/NK2GA receptor complex, as compared to
other T-IEL subsets.95
In addition to TCR stimulation, the expression of CD94 and its
respective receptor partners on some T cells subsets, has also
been linked to exposure to IL-15.105–107 In line with this, Jabri
et al.104 reported that, in vitro, IL-15 alone was as effective as
TCR-stimulation in upregulating CD94 expression in human T-IEL
but not in CD8+ peripheral blood lymphocytes (PBLs). In coeliac
disease, where there is chronic heightened expression of IL-15
by stressed epithelial cells, increased expression of CD94 and
the activating CD94/NKG2C heterodimer, with a concomitant
decrease of NKG2A on T-IEL has been observed.104,108 CD8+
TCRγδ T-IEL that express NKG2A are also decreased in active
coeliac disease and these cells can suppress the cytotoxic
programming of TCRαβ T-IEL, dependent on CD94/NKG2A
engagement and TGFβ production.109 This suggests CD94
inhibitory function is lost in coeliac disease. Stimulation assays
showed that NKG2C engagement increased proliferation and
cytokine production of human T-IEL isolated from coeliac
disease patients. In conjunction with the drastic upregulation
of the HLA-E on enterocytes in coeliac disease as compared to
healthy individuals, these data suggest that selective upregula-
tion of the CD94/NKG2C in place of inhibitory CD94/NKG2A may
be a mechanism of tipping the balance toward effector function
of T-IEL in disease (Table 2).
2B4
2B4 (also known as SLAMF4 and CD244) is a member of the
signaling lymphocyte activation molecule (SLAM) family, part of the
immunoglobulin (Ig) domain containing superfamily (Fig. 2), and
has two isoforms, a short and a long, derived from alternate splicing.
It can function as both an activating and inhibitory receptor,
depending on which splice variant is expressed, the density and
glycosylation of the receptor or the availability of the signaling
adapters, SLAM-associated protein (SAP) and Ewing’s sarcoma-
associated transcript 2 (EAT-2).110 Its ligand is CD48 (SLAMF2). 2B4 is
expressed by NK cells, and small populations of other lymphoid cells
including DETC. Its expression on DETC is associated with cell
activation, proliferation, and cytokine secretion.111
Gut microbiota products and CD70 co-stimulation both induce
2B4 expression on T-IEL in mice.112,113 It is therefore not surprising
that 2B4 is found on almost all murine and human CD8+ T-IEL,
although 2B4 is expressed more highly on CD8αα compared to
CD8αβ T-IEL.112,114 Using Slamf4−/− mice, and anti-SLAMF4
antibodies in combination with anti-CD3 stimulation, O’Keeffe
et al., showed that 2B4 depletion or blockade in the context of
anti-CD3 injections in mice induced CD8αβ T-IEL proliferation,
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cytokine production and increased T-IEL cytotoxicity, leading to
higher gut inflammation.114 Higher gut inflammation was also
found in EAT-2-deficient mice compared to WT after anti-CD3
challenge. These results suggest a negative regulatory role of 2B4
in T-IEL, after TCR triggering, probably mediated through the EAT-
2 adapter protein (Fig. 2 and Table 2). However, a recent study
using Slamf4−/− mice showed that 2B4 expression drove a
stronger protective immune response to oral Citrobacter and
Listeria infections, and this correlated with reduced cytokine
production from Slamf4−/− T-IEL compared with WT T-IEL
in vivo.113 These two studies are yet to be reconciled, although
it should be pointed out that the earlier study mainly relied on
anti-CD3 stimulation, a non-physiological stimulus. However, as
CD48 can also signal into intestinal cells, and different subsets of
T-IEL may express different isoforms of 2B4 and/or the adapters,
the context of 2B4 triggering and the cell types involved in the
intestine may decide the outcome.
OTHER REGULATORY RECEPTORS
T-IEL express other regulatory receptors whose functions have
never been studied in depth or in vivo (Table 2). For example,
expression of JAML, a member of the Junctional Adhesion
Molecule (JAM) family,115 a group of adhesion receptors in the
Immunoglobulin (Ig) superfamily (Fig. 1) that regulate cell–cell
interactions and leukocyte transmigration,116 has been char-
acterized as a costimulatory receptor on DETC and intestinal γδ
T-IEL.117 The JAML ligand was identified as the Coxsackie and
Adenovirus Receptor (CAR), a member of the JAM family
expressed on the surface of keratinocytes and IEC.117,118 In
epidermal and intestinal γδ T cells, in vitro ligation of JAML in
conjunction with TCR stimulation led to enhanced proliferation
and production of the cytokines IL-2, Tumor Necrosis Factor-α
(TNFα) and IFNγ as compared to TCR stimulation alone.117
Surprisingly, although JAML was expressed on both γδ and αβ T-
IEL, anti-JAML antibodies only served to costimulate prolifera-
tion of γδ T-IEL. As JAML function in T-IEL has only been studied
in vitro, it is still unclear whether JAML stimulation contributes
to the functions of intestinal T-IEL in an in vivo setting.
Expression of another T cell costimulator, OX40 (also known as
CD134 and TNFRSF4) is induced on all murine CD8+ T-IEL by
in vitro anti-CD3 stimulation.119 Its expression is associated with
IFN-γ production and enhanced T-IEL cytotoxicity. In vitro co-
stimulation of T-IEL with anti-CD3 and anti-OX40 resulted in
decreased IL-10 production compared with anti-CD3 stimulation
alone (Table 2). Interestingly, while OX40L is not generally
expressed on IEC or by T cells, anti-CD3 stimulation induced
expression of OX40L on T-IEL, suggesting T-IEL potentially interact
with each other via OX40 and OX40L. However, the relevance of
this interaction has not been tested in vivo, and may be an
artefact of in vitro culture systems.
In humans, a population of colonic CD8αβ+ γδ T-IEL that
express Vδ1 constitutively express high levels of NKp46,120 a
member of the natural cytotoxicity receptors family (NCR),
normally found on NK cells.121 In vitro cytotoxic assays against
K562 and colon adenocarcinoma cell lines showed that NKp46
expression on Vδ1 T-IEL is associated with high cytotoxic potential
and IFNγ production. NKp46 expression is modulated by
cytokines, as IL-2 and IL-15 upregulate the receptor expression
on Vδ1 thymocytes.120 In line with this, NKp46 was also found on
human CD8αβ+ αβ T-IEL in patients with coeliac disease. Similar to
NKp46+ Vδ1+ T-IEL, T-IEL cell lines derived from those patients
showed increased cytotoxicity and cytokine production.108 Both
studies also found expression of NKp44 on human T-IEL (Table 2).
These studies suggest that NCR expression on T-IEL is associated
with an activated, effector phenotype.
In addition to the regulatory receptors mentioned, gene
expression studies revealed that T-IEL express many other
costimulatory and inhibitory receptors. Murine T-IEL express mRNA
for LAG-3, NKR-P1A, 4-1BB, gp49/LILRB4, TIGIT, PD-1, and CTLA-493,94
(Table 2). Protein level expression of LAG-3,10,94 TIGIT,35 and Gp49112
on CD8αα T-IEL has been confirmed by flow cytometry, while CTLA-
4 is only expressed on CD8αβ+ αβ T-IEL.10 Although the functions of
these receptors on other adaptive CD4+ and CD8+ T cells, and on
intestinal T cells is well described and has been reviewed recently,122
to our knowledge, their role on T-IEL has never been studied.
CONCLUSION AND PERSPECTIVES
In this review, we have focused on exciting advances on the TCR
specificities of innate-like T-IEL, and on the plethora of novel
signaling receptors that T-IEL express. Although the function of
some of these is beginning to be unraveled in induced and innate-
like T cells, their role in T-IEL activation and function is still unclear.
Thus, the fundamental question of how T-IEL are activated remains
unanswered. As multiple studies have shown, T-IEL are the primary
immune responders to enteric infection and therefore must have a
rapid response mechanism. On the other hand, exacerbation of their
activation contributes to immune-mediated disorders such as IBD
and coeliac disease. Understanding what drives T-IEL activation and
what keeps them under control is crucial to developing therapeutic
strategies against those diseases.
Although TCR expression is now fairly well-established to be
necessary for agonist selection of αβ T-IEL in the thymus, and for
selection of γδ T-IEL in the intestine, whether TCR engagement is
necessary to fully activate T-IEL is still uncertain. To some extent, the
T-IEL TCR is functional, as anti-CD3 T-IEL stimulation induces
cytokine production and enhances T-IEL cytotoxicity. However,
signaling networks in IEL need elucidation as TCR triggering does
not lead to calcium release or phosphorylation of known down-
stream signaling effectors.50 The fact that T-IEL constitutively express
so many costimulatory receptors suggest that T-IEL probably require
more than one signal to be fully activated. Importantly, many of the
functional studies on costimulatory receptors have relied on anti-
CD3 costimulation, making it difficult to be certain about the
physiological relevance of these studies. The activation signals may
also be context-dependent, which makes the task of understanding
how T-IEL get activated even more complex.
In summary, two possibilities for TCR-driven activation of T-IEL
still remain - either the TCR on innate-like T-IEL is constitutively
engaged, and release from inhibitory signals are necessary to
trigger T-IEL activation, or there are as yet unknown TCR ligands
that are upregulated upon stress, and these, together with
costimulatory receptors, trigger activation of T-IEL. A third TCR-
independent possibility is that the TCR on T-IEL is only required for
the selection and retention of T-IEL in the intraepithelial space,
and cytokines, together with activating receptors such as NKG2D
trigger T-IEL activation, completely independent of TCR engage-
ment. Notably, in our review of the literature, we did not find any
evidence of activating receptors triggering T-IEL activation with-
out prior exposure of T-IEL to cytokines and/or TCR stimulation.
The challenge in the future will be to evaluate how T-IEL integrate
information from multiple receptors to trigger an effector
response. New mouse models that allow conditional deletion of
coreceptors on T-IEL, in vitro T-IEL:epithelial coculture systems,
such as those involving organoids123 and phosphoproteomic
studies may help to provide new insights into the mechanisms
driving T-IEL activation.
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